IN8BIO, INC. — Investor Relations & Filings
IN8BIO, INC. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell therapies for solid and hematological tumors. The company's proprietary DeltEx™ platform utilizes allogeneic, autologous, and genetically modified approaches to develop novel cell therapies. IN8BIO was the first to advance genetically modified gamma-delta T cells into clinical trials. Its lead product candidates include INB-400, a Phase 2 asset for newly diagnosed glioblastoma (GBM), and INB-100, a Phase 1 candidate for patients with leukemia undergoing hematopoietic stem cell transplantation. The company is also advancing a broad portfolio of preclinical programs focused on solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3/A | 2026-05-18 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | |
| S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46474546 | S-3/A | 2026-05-18 | English | ||
| 43589305 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589284 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589220 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589208 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43589206 | S-8 POS - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43596317 | S-8 - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 43518284 | 8-K - IN8BIO, INC. (0001740279) (Filer) | 2026-05-07 | English | ||
| 33052209 | ARS - IN8BIO, INC. (0001740279) (Filer) | 2026-03-26 | English | ||
| 32897569 | 8-K - IN8BIO, INC. (0001740279) (Filer) | 2026-02-27 | English | ||
| 31546757 | 8-K Filing | 2026-02-09 | English | ||
| 31546837 | 4 Filing | 2026-02-06 | English | ||
| 31546738 | 4 Filing | 2026-02-06 | English | ||
| 31546677 | 4 Filing | 2026-02-06 | English | ||
| 31546594 | 4 Filing | 2026-02-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
IN8BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35200/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35200 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35200 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35200 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35200}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IN8BIO, INC. (id: 35200)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.